US Drug Recall Register

FDA Drug Recalls

11,815 recalls · Class II, newest first

Class II · Moderate risk Terminated

Sermorelin Acetate 9 mg / Vial

Reason Lack of Assurance of Sterility

KRS Global Biotechnology, Inc D-0099-2020
Class II · Moderate risk Terminated

Sermorelin Acetate 3 mg / Vial

Reason Lack of Assurance of Sterility

KRS Global Biotechnology, Inc D-0098-2020
Class II · Moderate risk Terminated

Sermorelin Acetate 9 mg/ 3 mL

Reason Lack of Assurance of Sterility

KRS Global Biotechnology, Inc D-0097-2020
Class II · Moderate risk Terminated

Sermorelin 9 mg / GHRP6

Reason Lack of Assurance of Sterility

KRS Global Biotechnology, Inc D-0096-2020
Class II · Moderate risk Terminated

Sermorelin

Reason Lack of Assurance of Sterility

KRS Global Biotechnology, Inc D-0095-2020
Class II · Moderate risk Terminated

Sermorelin Acetate

Reason Lack of Assurance of Sterility

KRS Global Biotechnology, Inc D-0094-2020
Class II · Moderate risk Terminated

Sermorelin Acetate

Reason Lack of Assurance of Sterility

KRS Global Biotechnology, Inc D-0093-2020
Class II · Moderate risk Terminated

Quadmix # 19

Reason Lack of Assurance of Sterility

KRS Global Biotechnology, Inc D-0092-2020
Class II · Moderate risk Terminated

Quadmix #13A

Reason Lack of Assurance of Sterility

KRS Global Biotechnology, Inc D-0091-2020
Class II · Moderate risk Terminated

Polidocanol 5%

Reason Lack of Assurance of Sterility

KRS Global Biotechnology, Inc D-0090-2020
Class II · Moderate risk Terminated

PHENYLephrine HCl 1.5%

Reason Lack of Assurance of Sterility

KRS Global Biotechnology, Inc D-0085-2020
Class II · Moderate risk Terminated

Phenylephrine HCl 1.5%

Reason Lack of Assurance of Sterility

KRS Global Biotechnology, Inc D-0084-2020
Class II · Moderate risk Terminated

Nicotinamide Adenine Dinucleotide

Reason Lack of Assurance of Sterility

KRS Global Biotechnology, Inc D-0079-2020
Class II · Moderate risk Terminated

NEOstigmine Methylsulfate

Reason Lack of Assurance of Sterility

KRS Global Biotechnology, Inc D-0078-2020
Class II · Moderate risk Terminated

NEOstigmine Methylsulfate

Reason Lack of Assurance of Sterility

KRS Global Biotechnology, Inc D-0077-2020
Class II · Moderate risk Terminated

Moxifloxacin 0.1% in BSS

Reason Lack of Assurance of Sterility

KRS Global Biotechnology, Inc D-0076-2020
Class II · Moderate risk Terminated

Moxifloxacin 0.1% in BSS

Reason Lack of Assurance of Sterility

KRS Global Biotechnology, Inc D-0075-2020